Streetbeat News

Legal

BA

Boeing Company (NYSE:BA) shares have declined over 5% in the past five days amid ongoing scrutiny of its safety and quality standards. A new whistleblower has raised concerns about the 787 Dreamliners' fuselage sections, leading to a Senate hearing on Boeing's safety culture. Analysts from JP Morgan and B of A Securities have lowered their price targets for Boeing. Despite this, the average 1-year price target from analysts suggests a 37.8% upside in 2025.

Portfolio Pulse from Erica Kollmann

April 12, 2024 | 2:55 pm

GL

Globe Life Inc. (NYSE:GL) shares experienced significant volatility, dropping over 50% Thursday after a short report from Fuzzy Panda Research alleging insurance fraud, then rebounding Friday on heavy trading volume. The company refuted the claims. Analysts have mixed ratings on GL, with an average 12-month price target of $121.86, suggesting potential upside.

Portfolio Pulse from Erica Kollmann

April 12, 2024 | 2:54 pm

WFC

Wells Fargo's CFO announced in a conference call that the bank faces potential operating losses due to outstanding litigation, regulatory issues, and customer remediation matters for the remainder of the year.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 2:19 pm

ZTS

Zoetis shares are trading lower after a Wall Street Journal report titled "What Killed Their Pets? Owners Blame Meds, but Vets Aren't Sure." This report has raised concerns among pet owners and investors regarding the safety and reliability of Zoetis' products, potentially impacting the company's stock performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 2:06 pm

BA

LUV

UAL

Southwest Airlines expects fewer Boeing jet deliveries this year, impacting its growth. Initially planning for 85 Boeing MAX jets, now only about 20 are expected due to Boeing's production cuts and regulatory issues. This reduction affects Southwest's operational targets and financial outlook, with similar challenges faced by United Airlines.

Portfolio Pulse from Shivani Kumaresan

April 12, 2024 | 1:31 pm

ZTS

The Wall Street Journal reported on concerns among pet owners who blame Zoetis' arthritis medications for the deaths of their pets, although veterinarians remain uncertain about the cause. Zoetis maintains that side effects are rare and asserts the safety of its products.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 1:30 pm

PARA

PARAA

Paramount Global (NASDAQ:PARA) (NASDAQ:PARAA) is facing shareholder concerns over a potential merger with Skydance Media, with fears of not exploring competitive bids and the fairness of a $4 billion to $5 billion stock deal. Ariel Investments and Mario Gabelli are advocating for a fair review of alternatives and equal treatment for all shareholders, respectively. Paramount has entered a 30-day exclusive negotiation with Skydance, while also being in talks for a deal involving National Amusements' controlling interest. This follows an earlier $26 billion offer from Apollo Global Management.

Portfolio Pulse from Benzinga Neuro

April 12, 2024 | 12:53 pm

GL

NXPL

PXMD

PaxMedica (PXMD) shares surged 171% after announcing the completion of pivotal batches of PAX-101. NextPlat (NXPL) shares rose 98% with an increase in FY23 revenue. Globe Life (GL) shares increased 14% despite a short report from Fuzzy Panda Research, which the company refuted.

Portfolio Pulse from ryanfaloona@benzinga.com

April 12, 2024 | 12:43 pm

GL

Globe Life shares experienced increased volatility and traded higher after a short report from Fuzzy Panda Research. The company responded by refuting the allegations in the report.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 12:41 pm

ADAP

Adaptimmune Therapeutics announced that its unit received a notice of termination for its strategic collaboration and license agreement with Genentech. The termination will be effective 180 days after receipt, resulting in Adaptimmune not being entitled to further milestones or payments post-termination.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 12:13 pm